《大行報告》麥格理:新能源車OEMs偏好比亞迪(01211.HK) 納入主題名單
麥格理髮表報告指,全球轉向採用電動車爲具有技術和規模的企業提供機會,比亞迪(01211.HK)將會在這一個轉變中,成爲主要贏家之一,基於其成本基礎優越和刀片電池技術、以及電動車平臺的規模。該行指,儘管價格競爭戰激烈,比亞迪透過強而有力的成本控制和垂直整合來提升盈利能力,未來兩至三年期間,比亞迪可透過出口加速增長從而帶動盈利。
該行指,比亞迪擁有清晰的市佔目標,願意採取策略對抗價格戰,又指僅視此爲短期關注點,主要是比亞迪的成本基礎優越,令集團不會因小失大。該行在新能源車OEMs之間偏好比亞迪,首予其H股目標價310元,評級「跑贏大市」,並納入主題名單。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.